文献速递血栓与止血

成人巨细胞病毒相关血小板减少症的特征与结局:病例系列及文献综述

Characteristics and outcomes of adults with cytomegalovirus-associated thrombocytopenia: a case series and literature review.
PubMed 文献 · Br J Haematol · 2020-08-03

该研究通过系统文献复习纳入23篇文献报告的25例患者,并在以色列所有血液学中心检索到5例新的成人免疫功能正常巨细胞病毒相关血小板减少症病例,合计30例。中位年龄33岁(范围18-80),73%为男性,77%有巨细胞病毒相关症状,48%脾大,95%外周血见非典型淋巴细胞,68%转氨酶升高。一线含激素方案应答率仅31%,而接受抗巨细胞病毒治疗的11例应答率为82%,接受血小板生成素受体激动剂的4例中3例(75%)有应答。

要点

  • 成人巨细胞病毒相关血小板减少症患者中95%外周血见非典型淋巴细胞,68%转氨酶升高。
  • 一线含激素方案应答率仅31%,抗巨细胞病毒治疗应答率82%。
  • 血小板生成素受体激动剂治疗4例中3例(75%)有应答。

核心结论

  • 巨细胞病毒感染相关血小板减少症具有可识别的临床特征,应警惕巨细胞病毒感染作为血小板减少的原因。
  • 激素在不足三分之一的病例中有效,而抗巨细胞病毒治疗和血小板生成素受体激动剂均显示出极好的疗效,作者认为这些药物应更早引入治疗疗程。

研究设计与样本

  • 系统文献复习检索到23篇文献报告25例患者,并在以色列所有血液学中心检索到5例新的成人免疫功能正常巨细胞病毒相关血小板减少症病例,合计30例。

主要发现

  • 合计30例患者中位年龄33岁(范围18-80),73%为男性,77%有巨细胞病毒相关症状,48%脾大,95%外周血见非典型淋巴细胞,68%转氨酶升高。
  • 一线含激素方案应答率仅31%,而接受抗巨细胞病毒治疗的11例患者应答率为82%。
  • 接受血小板生成素受体激动剂的4例患者中3例(75%)有应答。

临床怎么用

  • 作者认为,具有上述血小板减少症特征性表现的病例应警惕巨细胞病毒感染作为病因。
  • 作者认为,抗巨细胞病毒治疗和血小板生成素受体激动剂均显示出极好疗效,这些药物应更早引入治疗疗程。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cytomegalovirus (CMV) is a ubiquitous virus that infects people worldwide. CMV is known to trigger thrombocytopenia, but this association is probably underdiagnosed since CMV infection in healthy adults is usually either asymptomatic or causes only mild symptoms. A systematic literature review was carried out and yielded 23 publications that reported 25 patients. All haematology centres in Israel were searched for adult immunocompetent patients with CMV-associated thrombocytopenia, and five new cases were identified. The median age of the combined 30 patients was 33 years (range 18-80), 73% were men, 77% presented with CMV-related symptoms, 48% had enlarged spleens, 95% had atypical lymphocytes in peripheral blood and 68% had elevated transaminase levels. The response rate to first-line steroid-containing regimens was only 31%, whereas 11 patients who were treated with an anti-CMV agent had a response rate of 82%. Moreover, four patients received thrombopoietin receptor agonists (TPO-RA) to which three (75%) responded. Taken together, these distinctive features of a case with thrombocytopenia should alert to CMV infection as the source. While steroids were effective in less than one-third of the cases, both anti-CMV therapy and TPO-RA exhibited excellent efficacy, suggesting that those agents should be introduced earlier in the therapeutic course.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Shragai T, Lebel E, Deshet D, et al. Characteristics and outcomes of adults with cytomegalovirus-associated thrombocytopenia: a case series and literature review. Br J Haematol. 2020. PMID: 32744725. doi:10.1111/bjh.17017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。